0001437749-23-034361.txt : 20231213 0001437749-23-034361.hdr.sgml : 20231213 20231213171542 ACCESSION NUMBER: 0001437749-23-034361 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231211 FILED AS OF DATE: 20231213 DATE AS OF CHANGE: 20231213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LeMaitre George W CENTRAL INDEX KEY: 0001365737 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33092 FILM NUMBER: 231484913 MAIL ADDRESS: STREET 1: 342 BUNKER HILL STREET, #2B CITY: CHARLESTOWN STATE: MA ZIP: 02129 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC CENTRAL INDEX KEY: 0001158895 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 63 SECOND AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 781-221-2266 MAIL ADDRESS: STREET 1: 63 SECOND AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 4 1 rdgdoc.xml FORM 4 X0508 4 2023-12-11 0001158895 LEMAITRE VASCULAR INC LMAT 0001365737 LeMaitre George W C/O LEMAITRE VASCULAR, INC. 63 SECOND AVENUE BURLINGTON MA 01803 1 1 1 Chairman and CEO 0 Common Stock 2023-12-11 4 M 0 30 0 A 2269505 D Common Stock 2023-12-11 4 F 0 642 54.40 D 2268863 D Common Stock 2023-12-12 4 M 0 14 0 A 2268877 D Common Stock 2023-12-12 4 F 0 652 53.81 D 2268225 D Dividend Equivalent Rights 2023-12-11 4 M 0 30 0 D Common Stock 30 60.2749 D Dividend Equivalent Rights 2023-12-12 4 M 0 14 0 D Common Stock 14 44.8348 D Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/11/2021. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/12/2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/11/2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. /s/ David C. Hissong 2023-12-13